Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C

Clin Immunol. 2019 Mar:200:16-18. doi: 10.1016/j.clim.2018.12.019. Epub 2019 Jan 7.

Abstract

Severe combined immunodeficiency (SCID) can be caused by deleterious mutations in DCLRE1C, leading to deficient non-homologous end joining by compromising the function of the Artemis protein. This impairs the process of V(D)J recombination of the T- and B-cell receptors and typically results in radiosensitive T-, B-, NK+ SCID presenting during the first months of life. We present a case of a 3-year-old girl with two novel compound heterozygous variants in DCLRE1C (c.58G>C and c.374A>C) that were associated with marked reduced numbers of peripheral T- and B-cells and undetectable total serum IgG. Despite the severe laboratory phenotype, the patient had a normal development, albeit failure to thrive (-2.5 to -3 SD), during her first years of life including day-care attendance at preschool for 1.5 years. After being diagnosed with pneumonia the clinical picture of SCID was recognized and the girl successfully underwent hematopoietic stem-cell transplantation.

Keywords: Agammaglobulinemia; Artemis; DCLRE1C; Severe combined immunodeficiency.

Publication types

  • Case Reports

MeSH terms

  • Agammaglobulinemia / complications
  • Agammaglobulinemia / genetics*
  • Agammaglobulinemia / immunology
  • Child, Preschool
  • DNA-Binding Proteins / genetics*
  • Endonucleases / genetics*
  • Female
  • Heterozygote
  • Humans
  • Mutation
  • Pneumonia, Pneumocystis / diagnosis
  • Pneumonia, Pneumocystis / etiology
  • Severe Combined Immunodeficiency / complications
  • Severe Combined Immunodeficiency / diagnosis
  • Severe Combined Immunodeficiency / genetics*
  • Severe Combined Immunodeficiency / immunology

Substances

  • DNA-Binding Proteins
  • DCLRE1C protein, human
  • Endonucleases